2nd Annual National Opioid Crisis Management Congress
September 27-28, 2018 * Omni Shoreham Hotel * Washington, DC
2nd Annual National Opioid Crisis Management Congress
About the Conference
National attention is focused on the opioid crisis, and communities are struggling to respond. According to the U.S. Centers for Disease Control, as the clinical use of opioids has risen over the past two decades, opioid-associated harm has risen in parallel.
Chronic pain affects approximately 100 million Americans, making it one of the most common reasons for patients to seek medical care. Over the past decade, there has been a four-fold increase in opioid prescribing. During the same time period, there was a four-fold increase in unintentional opioid overdose deaths and a five-fold increase in substance abuse treatment admissions for prescription opioid addiction.
The ongoing opioid crisis lies at the intersection of two substantial public health challenges—reducing the burden of suffering from pain and containing the rising toll of the harms that can arise from the use of opioid medications.
This conference will address the state of the science in pain management, characterize the epidemiology of the opioid epidemic, and identify actions that can be taken to respond to this crisis. Gain expert insight into an epidemic from top thought leaders in opioid management who will share their latest research and real-world knowledge in the evolving paradigm of opioids in medicine. In addition, experts at the state and federal levels providing leadership on the opioid public health crisis will present developing collaborative strategic partnerships to serve our most vulnerable citizens.
Who Should Attend?
From Hospitals/Health Systems/Health Plans/Gov’t Agencies/Law Enforcement
- Medical Directors
- Behavioral Health Directors
- Pharmacy Directors
- Clinical Pharmacists
- Social Workers
- Outreach Coordinators
- PDMP Directors
- Pain Management Directors
- Telehealth Directors
- State Health Directors
- Nursing Director
- Emergency Room Directors
- Substance Abuse & Prevention Directors
- Law Enforcement
- Narcotic Enforcement
- Quality Improvement Director
- Family Services Director
- Clinical Directors
- Compliance Director
- Correctional Coordinators
This Event Will Also be if Interest to:
- Pharmaceutical Companies * Law Firms * Consultants * Drug Development Companies
Day One – Thursday, September 27, 2018
7:15am – 8:00am
Registration & Networking Breakfast
8:00am – 8:15am
Chair’s Opening Remarks
8:15am – 9:00am
Keynote: The Opioid Crisis: Federal and State Regulation of Opioids
This keynote will address federal and state regulations that are swiftly changing to address the current opioid epidemic.
9:00am – 9:45am
Safer and Effective Opioid Prescribing Practices
Providers who prescribe opioids to treat chronic pain are in a key position to balance the benefits and risks of chronic opioid therapy (COT). However, providers struggle with the need to assist their patients with adequate management of chronic pain while confronting the risks associated with opioid prescribing. This session will provide recommendations for safer and more effective prescribing of opioids. Topics will include:
- Identify opioid practice updates as outlined in the CDC opioid guidelines
- Monitoring and documentation strategies to meet best practice standards and medical and legal requirements
- Apply a practical framework for decision-making on the initiation, dosage modification, and when and how opioids should be discontinued
- Tools to adequately assess risk in patients being considered for opioid therapy
- Limiting the use of opioid prescriptions for combatting pain and recommending new treatments for pain management without the use of addictive substances
9:45am – 10:15am
10:15am – 11:00am
How Insurers Can Help Fight the Opioid Epidemic
Of the approximately 100 million Americans who take prescription opioids each year, almost 3 million receive their prescriptions from five to as many as 20 different physicians. The practice, often called “doctor shopping,” allows opioid-addicted individuals to consume an enormous and dangerous number of pills with the unwitting help of doctors. Doctor shopping also lets drug dealers use the healthcare system to subsidize their business. Doctor shopping is possible because none of the doctor shoppers’ prescribers knows that they are only one of many providers of opioids. Enter someone with full information: the insurer. This session will discuss the role of health plans in curbing the opioid crisis. Topics will include:
- Using innovative data analysis to monitor opioid prescribing of providers
- “Reimbursement lock-in,” (when the enrollee’s prescriptions for opioids will only be covered if they are written by a single provider of the patient’s choosing)
- Implementing a pharmacist-led medication therapy management program
- Steps to curb the abuse of opioid prescriptions
11:00am – 11:45am
Medication-Assisted Treatment and New Models of Care for Opioid Use Disorder
The occurrence of opioid use disorder (OUD, opioid abuse/addiction) is a concern shared by many clinicians who prescribe opioids in the context of pain management. This session will review rates of OUD in chronic pain patients, behaviors associated with OUD, and epidemiology of OUD in Americans and treatment of OUD. Medication-assisted treatment for OUD will be addressed as will new models of care for this population.
11:45am – 1:00pm
1:00pm – 1:45pm
FDA Perspective: Regulatory Requirements and Evolving Methods of Abuse-Deterrent Approaches
A call for informed professionals to engage in a discussion of timely opioid-related policy matters, this session will address the regulatory requirements and evolving methods for evaluating abuse deterrent approaches, as well as emerging data to determine if an abuse-deterrent approach is effective in mitigating prescription opioid abuse and misuse. Topics will include:
- The assessment, treatment, and outcomes of pain in patients at risk for prescription opioid abuse
- Broader policy initiatives, including the FDA’s requirement for black box warnings on all prescription opioids
1:45pm – 2:30pm
Collaboration Between Opioid Treatment Programs and Community Partners
Reducing the Community Prescribed Opioid Load as a Harm Reduction Strategy
In response to the heightened risks associated with the use of opioids, this session will discuss community safety strategies to reduce the harm imposed by opioids on communities and help to control the opioid epidemic. Topics will include:
- Best practice in opioid prescribing and monitoring to reduce the quantity of opioids in circulation
- Strategies to assist healthcare partnerships and collaborations by advancing their understanding of medication-assisted treatment as a crucial element to community wellness in an era of healthcare reform
- The essential role that the community plays in recovery support and prevention
2:30pm – 3:00pm
3:00pm – 4:15pm
Panel: Responding to a Public Health Crisis: Opioid Use, Misuse, and Abuse
This session will provide an overview of practical tools and strategies to understand the critical aspects of prescription pain medications while managing the ever-increasing challenges associated with prescribing opioids. It will include a framework for considerations of opioid therapy in treatment regimens and address concerns that arise in the practice setting.
4:15pm – 5:00pm
Integrated and Coordinated Opioid Treatment Care
Research has proven that effective care coordination increases efficiency and improves clinical outcomes and patient satisfaction. This session will assist you in the development of strategies to improve the collaboration between opioid treatment providers and the systems needed to coordinate care.
End of Day One
Day Two – Friday, September 28, 2018
7:15am – 8:00am
8:00am – 8:15am
8:15am – 9:00am
State Medical Board Perspective
This session will discuss the role and perspective of state medical boards in the oversight of opioid therapy for pain management.
9:00am - 9:45am
Maximizing the Effectiveness and Safety of Opioids
Pain is among the most common complaints in primary care, including those with chronic symptoms. Taken as prescribed, opioids can be used to manage pain safely and effectively. They are cost effective and allow increased numbers of patients to return to active productive lives in society. Yet, while opioids have been with us for over 4,000 years, the landscape of opioid therapies is rapidly evolving. New formulations and treatment options are emerging that may reduce inherent risk to patients. Education is key to staying current and maximizing the effectiveness of opioids in clinical practice. Topics will include characteristics about various opioids, untangling the complexities of applying opioid conversions to patient care, and more.
9:45am – 10:15am
10:15am - 11:00am
Behavioral Health: Increasing Access to Care Treatment and Services
Behavioral health is an important means to unite the diverse components of an individual’s care in order to insure that care, treatment and services provided are accessible, family-centered, continuous, comprehensive, coordinated, compassionate and culturally effective. With the advent of healthcare reform, an increasing number of behavioral healthcare organizations have sought to offer integrated primary healthcare for the individuals and families that they serve. This session will discuss the decision making process for behavioral healthcare organizations considering offering integrated care, with a focus on how the provision of medication assisted treatment is included in that process.
11:00am – 11:45pm
Communicating Messages to Influence Public Perception
Opioid treatment programs have been the target of negative public opinion and adverse media coverage. This has affected the ability to effectively influence national drug policy, explain the science of opioid addiction and treatment, gain the funding necessary to provide quality treatment to all who require it, and ultimately operate in the best interests of patients and communities. This session will address key messages specifically designed to counter the stigma and stereotypes deeply embedded in the perception of opioid addiction and medication-assisted treatment.
11:45am – 12:30pm
Improving Access to Addiction Care
While connecting people to treatment and recovery support has been shown to be effective and can save lives, the addiction care system continues to face tremendous change and upheaval. This session will review recent developments aimed at improving access to addiction care, including medication-assisted treatment. Topics will include:
- Potential future developments related to substance use disorder treatment
- The future of medication assisted treatment, delivery system reforms, and opportunities available for improving policy moving forward
- Strategies for getting ahead of the problem, and how upstream prevention action can restore hope and lead to a brighter and healthier future for generations to come
Omni Shoreham Hotel
2500 Calvert Street NW
Washington, DC 20008
Mention BRI Network to get the discounted rate of $209/night
Sponsors and Exhibitors
Are there group discounts available?
- Yes – Register a group of 3 or more at the same time and receive an additional 10% off the registration fee
Are there discounts for Non-Profit/Government Organizations?
- Yes – please call us at 800-743-8490 for special pricing
What is the cancellation policy?
- Cancellations received 3 weeks prior to the event will receive a refund minus the administration fee of $185. Cancellation received less than 3 weeks prior to the event will receive a credit to a future event valid for one year.
Can the registration be transferred to a colleague?
- Yes – please email us in writing at firstname.lastname@example.org with the colleague’s name and title
Where can I find information on the venue/accommodations?
- Along with your registration receipt you will receive information on how to make your hotel reservations. You can also visit individual event page for specific hotel information. The conference fee does not include the cost of accommodations.
What is the suggested dress code?
- Business casual. Meeting rooms can sometimes be cold so we recommend a sweater or light jacket